Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Traws Pharma, Inc. - Common Stock
(NQ:
TRAW
)
1.650
+0.170 (+11.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 6, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Traws Pharma, Inc. - Common Stock
< Previous
1
2
Next >
MAG 8 Momentum: NIVF, TRAW, KPRX, PNPN.V Lead $3 Undercard Surge – More Stocks Inside!
June 04, 2025
Via
AB Newswire
What's going on in today's session
June 03, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 03, 2025
Via
Benzinga
Which stocks are moving on Tuesday?
June 03, 2025
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Dow Gains Over 100 Points; US Job Openings Increase In April
June 03, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Tuesday's session: gap up and gap down stocks
June 03, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Tuesday.
Via
Chartmill
US Stocks Mixed; Dollar General Posts Upbeat Earnings
June 03, 2025
Via
Benzinga
Tuesday's pre-market session: top gainers and losers
June 03, 2025
The US market is yet to commence its session on Tuesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
June 03, 2025
Via
Benzinga
Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib
June 03, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Announces Receipt of FDA Guidance on Tivoxavir Marboxil and Reports Plans for Pursuing Stockpiling for Pandemic Preparedness
May 27, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports First Quarter 2025 Results and Business Highlights
May 15, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Reports Full Year 2024 Results and Business Highlights
March 31, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Announces Management Updates
March 28, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma to Host Investor Event on Bird Flu and COVID Product Candidates Virtual Event to be Held on Monday, March 31, 2025 at 10:00 AM ET
March 26, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma’s COVID-19 Candidate, Ratutrelvir, Presented at ICAR
March 25, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Antiviral Bird Flu Program, Tivoxavir Marboxil, Shows Positive Data in Non-human Primates
March 24, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma’s Bird Flu Drug Candidate, Tivoxavir Marboxil, Presented at ICAR
March 21, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Monday's pre-market session: top gainers and losers
March 03, 2025
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.
Via
Chartmill
Traws Pharma Reports Positive Results from An Accepted Bird Flu Model for Anti-Viral Candidate, Tivoxavir Marboxil
March 03, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Traws Pharma Regains Compliance with NASDAQ Equity Listing Rule
February 28, 2025
From
Traws Pharma, Inc.
Via
GlobeNewswire
Thursday's pre-market session: top gainers and losers
February 13, 2025
Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 16, 2025
Via
Benzinga
Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket
January 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 30, 2024
Via
Benzinga
Nasdaq Down Over 100 Points; US Pending Home Sales Increase In November
December 30, 2024
Via
Benzinga
Crude Oil Gains 1%; Chicago PMI Falls In December
December 30, 2024
Via
Benzinga
Exposures
Fossil Fuels
US Stocks Open Lower; Dow Tumbles 600 Points
December 30, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
December 24, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 23, 2024
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.